GSK Archives

News and Trends 2 Jan 2025

A surge in deals: GSK bets on ADC, neuro and fibrotic diseases to bolster drug development

Last month saw a number of alliances forming in a range of therapeutic spaces but there has been one serial collaborator that stands out – GSK.

January 2, 2025 - 6 minutesmins - By Roohi Mariam Peter

CureVac: From a failed mRNA-based COVID-19 vaccine to a €400 million deal with GSK

In Depth 1 Aug 2024

CureVac: From a failed drug to a €1.45 billion deal

In 2021, CureVac’s COVID-19 candidate came short. Discover how the company leveraged its deal with GSK to restructure and turn things around.

August 1, 2024 - 8 minutesmins - By Jules Adam

In Depth 3 Apr 2024

Hepatitis B: are we edging closer to a cure?

Find out whether we are closing in on a cure for hepatitis B – a virus affecting the liver that can cause acute and chronic disease.

April 3, 2024 - 9 minutesmins - By Willow Shah-Neville

News and Trends 21 Dec 2023

The big pharma race against deadly RSV steps up in 2023

GSK and Pfizer received FDA approval for their RSV vaccines in 2023. Now, AstraZeneca has joined the race with its latest acquisition.

December 21, 2023 - 7 minutesmins - By Roohi Mariam Peter

Neisseria gonorrhoeae gonorrhoea gonorrhea

News and Trends 27 Jun 2023

GSK gonorrhea vaccine fast tracked

The US Food and Drug Administration (FDA) has granted a Fast Track designation for GSK plc’s Neisseria gonorrhoeae investigational vaccine (NgG). The vaccine candidate is currently in an ongoing phase II trial and aims to demonstrate proof of concept by assessing the efficacy of the NgG vaccine in healthy adults, 18 to 50 years of […]

June 27, 2023 - 3 minutesmins - By Jim Cornall

More News! 6 Jun 2023

$5.5M funding for Oncopole to tackle cancer

Oncopole, Fonds de recherche du Québec – Santé (FRQS) cancer division in Canada, has received major investments that boost its public-private partnership model dedicated to the fight against cancer. Oncopole will continue to pursue its mission thanks to a $3 million reinvestment from founding partner Merck Canada. Oncopole, FRQS cancer division, is the result of […]

June 6, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 4 May 2023

World’s first RSV vaccine for older adults gets FDA approval

GSK plc says the US Food and Drug Administration (FDA) has approved Arexvy (respiratory syncytial virus vaccine, adjuvanted) for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older. It is the first RSV vaccine for older adults to be approved anywhere in […]

May 4, 2023 - 5 minutesmins - By Jim Cornall

Opinion 26 Apr 2023

How to address declining vaccination rates in older adults

By Philip Dormitzer, global head of vaccines research and development, GSK The vaccines landscape has changed greatly over the last few years in light of the COVID-19 pandemic. New technologies have been applied at scale, innovative vaccine programs rolled out, and supply chains rearranged to help tackle global health challenges. But, while innovation has improved […]

April 26, 2023 - 5 minutesmins - By External Contributor

BIO-Europe Spring, Element Materials Technology, Ergomed, Rentschler Biosciences

News and Trends 8 Mar 2023

How to promote diversity in STEM

Leaders from OMass Therapeutics, SiSaf and Brainomix explain how to promote diversity in science, technology, engineering and math (STEM). OMass Therapeutics is a female-led business with diversity at its core. It was founded by the pioneering scientist and Oxford Professor Dame Carol Robinson and is led by the experienced biotech and pharma executive Ros Deegan. […]

March 8, 2023 - 6 minutesmins - By Jim Cornall

Expert Advice 2 Mar 2023

5 steps to strategic partnerships for healthtech startups

By Varvara Melikhova, founder and CEO of Unison Innovations Strategic partnerships are a better way to build a product’s capabilities than outright acquisitions. While the M&A path is set out for the most mature successful startups, early-stage partnerships can enhance a product’s market value and provide access to Big Pharma expertise and infrastructure, which significantly […]

March 2, 2023 - 6 minutesmins - By External Contributor

News and Trends 10 Feb 2023

FDA approves GSK drug for recurrent or advanced mismatch repair-deficient endometrial cancer

GSK plc says the US Food and Drug Administration (FDA) has given full approval for Jemperli (dostarlimab-gxly) for the treatment of adult patients with mismatch repair-deficient (dMMR) recurrent or advanced endometrial cancer, as determined by a US FDA-approved test, that has progressed on or following a prior platinum-containing regimen in any setting and are not […]

February 10, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 9 Feb 2023

Cell and Gene Therapy Catapult boost for life science campus

The Cell and Gene Therapy Catapult (CGT Catapult), an independent U.K. innovation and technology organization specializing in the advancement of cell and gene therapies, has announced its involvement in the development of a major new campus for life science businesses in Stevenage. The new campus was announced by UBS Asset Management’s Real Estate & Private […]

February 9, 2023 - 3 minutesmins - By Jim Cornall

Resources

Categories

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

GSK

A surge in deals: GSK bets on ADC, neuro and fibrotic diseases to bolster drug development

CureVac: From a failed drug to a €1.45 billion deal

Hepatitis B: are we edging closer to a cure?

The big pharma race against deadly RSV steps up in 2023

GSK gonorrhea vaccine fast tracked

$5.5M funding for Oncopole to tackle cancer

World’s first RSV vaccine for older adults gets FDA approval

How to address declining vaccination rates in older adults

How to promote diversity in STEM

5 steps to strategic partnerships for healthtech startups

FDA approves GSK drug for recurrent or advanced mismatch repair-deficient endometrial cancer

Cell and Gene Therapy Catapult boost for life science campus

Subscribe to our newsletter to get the latest biotech news!

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!